DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
Firms / Mtvp Management, LLC
Mtvp Management, LLC
venture manager, reported GAV $28.8M across 1 vehicles
Importance
23
moderate
Active deployment
30
moderate
Emerging
0
low
Completeness
69
high
Freshness
100
high
Research priority
11
low
Identity and regulatory footprint
- Headquarters
- Menlo Park, CAadviserinfo.sec.gov
- Office address
- 325 SHARON PARK DR #903, Menlo Park, CA, 94025adviserinfo.sec.gov
- Business phone
- 650-644-6419adviserinfo.sec.gov
- Website
- HTTPS://WWW.MEDTECHVP.COM
- SEC adviser type
- exempt reporting adviseradviserinfo.sec.gov
- SEC exemption claimed
- venture capital fund adviseradviserinfo.sec.govItem 2.B(1): advises solely venture capital funds
- Latest Form ADV
- Mar 31, 2026
- Private funds reported
- 1 (1 venture capital funds)adviserinfo.sec.gov
- Private fund gross assets
- $21.7Madviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
- business email
- info@medtechvp.commedtechvp.compublished by the subject
- business phone
- 650-644-6419adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
12 observed deals
Stated (the firm’s website)
- Sectors
- medtech
- Stages
- not stated or not yet read
- Geography
- not stated
- Check size
- not stated; DFX does not estimate checks from round sizes
Observed (from deals on record)
Stage at participation: no observed deals yet
Stage at first entry: no observed deals yet
Sectors
unknown 70%Other Health Care 20%Other 10%
lead rate n/afollow-on rate n/anew logos, 12 months 12
Funds and vehicles
1 reported
| Vehicle | Type | Vintage | Lifecycle | Reported GAV | Owners | Form D sold | Latest Form D |
|---|---|---|---|---|---|---|---|
| Medical Technology Venture Partners I, LP | Fund | 2017 form d first sale | Harvest | $28.8M Mar 25, 2024 | 39 | $24.8M of $60.0M | Jan 29, 2018 |
GAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.
Investment team
19 current, 0 departed
Edward Chang
AssociateEdward Chang MD is Associate Professor of Neurological Surgery and...
Steve Hetts
AssociateSteven Hetts, MD, is an Associate Professor of Radiology in Residence...
Luca Tassan
Founder or executiveCEO of Scranton Enterprises, a diversified holding enterprise with...
Renee Ryan
Founder or executiveRenee is the CEO of Cala Health, Inc. Cala Health is a bioelectronic medicine ...
Casey Tansey
General partnerCasey Tansey has been a general partner at USVP since 2005. A veteran of...
Josh Makower
General partnerJosh is General Partner on NEA's healthcare team leading the...
Benjamin Ma
OtherDr. C. Benjamin Ma is chief of Sports Medicine at UCSF.
Daniel Lim
OtherThe focus of Dr. Lim’s research is on neural stem cells and neurogenesis.
Brook Byers
PartnerBrook Byers is a founding member of Kleiner Perkins Caufield & Byers.
Casey McGlynn
PartnerCasey McGlynn is a partner at Wilson Sonsini Goodrich & Rosati. Since joining the...
Christine Winoto
PartnerPartner
Javad Seyedzadeh
PartnerPartner
Peter Loescher
PartnerPartner
Radu Cautis
PartnerPartner & Managing Director
Radu Cautis
PartnerMember · since Feb 1, 2017
Thomas Glanzmann
PartnerPartner
Ajay Dharia
Venture partnerVenture Partner
Stephen Bonelli
Venture partnerVenture Partner / CFO
Chris Eso
Vice presidentChris Eso is Vice President of Corporate Development for Medtronic, specifically...
Investments on record
12 edges, 10 companies, 2 partner-attributed
“This investor” is the amount disclosed for this investor alone; it is unknown unless a source said it. The round size is the whole round.
Co-investors
3 relationships from shared deals, counted for the whole firm
Limited partners
0 disclosed
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Timeline
9 dated events
- Sep 16, 2026Centese, Inc. no longer listed on Mtvp Management, LLC's portfolio pageRemoved from portfolio pagePortfolioInferenceCentese, Inc.Venture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026Verana no longer listed on Mtvp Management, LLC's portfolio pageRemoved from portfolio pagePortfolioInferenceVeranaVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026Siris no longer listed on Mtvp Management, LLC's portfolio pageRemoved from portfolio pagePortfolioInferenceSirisVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026Reglign no longer listed on Mtvp Management, LLC's portfolio pageRemoved from portfolio pagePortfolioInferenceReglignVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026Novonate no longer listed on Mtvp Management, LLC's portfolio pageRemoved from portfolio pagePortfolioInferenceNovonateVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026Gtmednew no longer listed on Mtvp Management, LLC's portfolio pageRemoved from portfolio pagePortfolioInferenceGtmednewVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026Calahealth no longer listed on Mtvp Management, LLC's portfolio pageRemoved from portfolio pagePortfolioInferenceCalahealthVenture organization websites (about, team, portfolio, thesis, news pages)
- Mar 29, 2019Medical Technology Venture Partners I, LP first reported on Form ADV by Mtvp Management, LLC (Venture Capital Fund), GAV $30,836,758Fund first reported on Form ADVFundsFactMedical Technology Venture Partners I, LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 29, 2019Mtvp Management, LLC first filed Form ADV (ERA, venture capital fund adviser exemption)First SEC adviser filingOrganizationFactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Classification history
- Sep 12, 2026Micro VC (confirmed, 95%, cls-1)venture manager, reported GAV $28.8M across 1 vehicles
Evidence
43 observations from 3 sources